Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Giuseppe Fasolino actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kruse, V. & Neyns, B., 1 jun 2022, In: Melanoma Research. 32, 3, blz. 183-191 9 blz.Onderzoeksoutput: Article › peer review
3 Citaten (Scopus) -
Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report
Fasolino, G., Nelis, P. J., Ten Tusscher, M., Moschetta, L., De Grève, J. & Lefesvre, P., 20 jan 2022, In: Diagnostics (Basel, Switzerland). 2022, 12, blz. 1-7 7 blz., 249.Onderzoeksoutput: Article › peer review
Open Access -
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
Lambert, I., Fasolino, G., Awada, G., Kuijpers, R., Ten Tusscher, M. & Neyns, B., 5 jun 2021, In: BMC ophtalmol. 21, 1, 8 blz., 250.Onderzoeksoutput: Article › peer review
Open Access3 Citaten (Scopus) -
A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 1 mei 2021, In: Cancers (Basel). 13, 9, 13 blz., 2010.Onderzoeksoutput: Article › peer review
Open AccessBestand3 Citaten (Scopus)94 Downloads (Pure) -
A phase 2 clinical trial on trametinib and low-dose dabrafenib in advanced pretreated BRAF(V600)/NRAS(Q61R/K/L) wild-type melanoma (TraMel-WT): Interim efficacy and safety results.
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 20 mei 2021, In: Journal of Clinical Oncology. 39, 15, 9529.Onderzoeksoutput: Meeting abstract (Journal)
Open Access
Activiteiten
-
ocular toxicity related to new oncological treatment
Giuseppe Fasolino (Speaker)
19 jun 2021Activiteit: Talk or presentation at a conference
-
Manama Meeting UZBrussel
Pieter Jan Nelis (Chair) & Giuseppe Fasolino (Chair)
19 jun 2021Activiteit: Participating in or organizing an event at an external academic organisation
-
-
brussel retina meeting
Giuseppe Fasolino (Chair)
4 apr 2019 → 6 apr 2019Activiteit: Participating in or organizing an event at an external academic organisation
-
diabetic retinopathy
Giuseppe Fasolino (Speaker)
28 nov 2019Activiteit: Talk or presentation at a conference